Evidence map›Paper›PMID 24608438›Full record

ArticleDiabetes2014

The p75 neurotrophin receptor is required for the major loss of sympathetic nerves from islets under autoimmune attack.

Gerald J Taborsky, Qi Mei, Karin E Bornfeldt, Daryl J Hackney, Thomas O Mundinger

Open access · hybridAbstract read
In one paragraph

Article in Diabetes, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.0field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Neuroimmune regulation in the pancreas.Fundamental research · 2024
    Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Gerald J TaborskyDivision of Endocrinology/Metabolism, Veterans Affairs Puget Sound Health Care System, Seattle, WADivision of Endocrinology, Metabolism and Nutrition, Department of Medicine, University of Washington, Seattle, WA taborsky@u.washington.edu.
Qi MeiDivision of Endocrinology, Metabolism and Nutrition, Department of Medicine, University of Washington, Seattle, WA.
Karin E BornfeldtDivision of Endocrinology, Metabolism and Nutrition, Department of Medicine, University of Washington, Seattle, WADepartment of Pathology, University of Washington, Seattle, WADiabetes Obesity Center of Excellence, University of Washington, Seattle, WA.
Daryl J HackneySeattle Institute for Biomedical and Clinical Research, Seattle, WA.
Thomas O MundingerDivision of Endocrinology, Metabolism and Nutrition, Department of Medicine, University of Washington, Seattle, WA.
University of Washington · USSeattle Institute for Biomedical and Clinical Research · USVA Puget Sound Health Care System · US

Funding

Vector and Transgenic Mouse CoreP30DK017047 · NIDDK · UNIVERSITY OF WASHINGTON · PI Sakeneh Zraika · 1986 to 2026
$41.4M
Role of Serum Amyloid A in Diabetic Vascular DiseaseP01HL092969 · NHLBI · UNIVERSITY OF WASHINGTON · PI BORNFELDT, KARIN E. · 2008 to 2019
$23.5M
HYPERGLYCEMIA, PROTEIN KINASES AND SMOOTH MUSCLE GROWTHR01HL062887 · NHLBI · UNIVERSITY OF WASHINGTON · PI BORNFELDT, KARIN E. · 1998 to 2014
$4.7M
PANCREATIC NERVES IN HYPOGLYCEMIA AND EXERCISER01DK050154 · NIDDK · UNIVERSITY OF WASHINGTON · PI TABORSKY, GERALD J · 1997 to 2014
$3.4M
S100A9 and S100A8 in Diabetes and AtherosclerosisR01HL097365 · NHLBI · UNIVERSITY OF WASHINGTON · PI BORNFELDT, KARIN E. · 2010 to 2013
$1.6M
NHLBI NIH HHS P01 HL092969NHLBI NIH HHS P01-HL-092969NHLBI NIH HHS R01 HL062887NHLBI NIH HHS R01-HL-062887NHLBI NIH HHS R01 HL097365NHLBI NIH HHS R01-HL-097365NIDDK NIH HHS P30 DK017047NIDDK NIH HHS P30-DK-17047NIDDK NIH HHS R01 DK050154NIDDK NIH HHS R01-DK-50154
6 · The paper itself

Abstract

Our goal was to determine the role of the p75 neurotrophin receptor (p75NTR) in the loss of islet sympathetic nerves that occurs during the autoimmune attack of the islet. The islets of transgenic (Tg) mice in which β-cells express a viral glycoprotein (GP) under the control of the insulin promotor (Ins2) were stained for neuropeptide Y before, during, and after virally induced autoimmune attack of the islet. Ins2-GP(Tg) mice injected with lymphocytic choriomeningitis virus (LCMV) lost islet sympathetic nerves before diabetes development but coincident with the lymphocytic infiltration of the islet. The nerve loss was marked and islet-selective. Similar nerve loss, chemically induced, was sufficient to impair sympathetically mediated glucagon secretion. In contrast, LCMV-injected Ins2-GP(Tg) mice lacking the p75NTR retained most of their islet sympathetic nerves, despite both lymphocytic infiltration and development of diabetes indistinguishable from that of p75NTR wild-type mice. We conclude that an inducible autoimmune attack of the islet causes a marked and islet-selective loss of sympathetic nerves that precedes islet collapse and hyperglycemia. The p75NTR mediates this nerve loss but plays no role in mediating the loss of islet β-cells or the subsequent diabetes. p75NTR-mediated nerve loss may contribute to the impaired glucose counterregulation seen in type 1 diabetes.

Indexed as

AnimalsAutoimmunityDiabetes Mellitus, ExperimentalDiabetes Mellitus, Type 1FemaleGlycoproteinsInsulinIslets of LangerhansLymphocytic choriomeningitis virusMaleMiceMice, Inbred C57BLMice, TransgenicReceptors, Nerve Growth FactorSympathetic Nervous SystemViral ProteinsGlycoproteinsIns2 protein, mouseInsulinNgfr protein, mouseReceptors, Nerve Growth FactorViral Proteins

Identifiers

PMID24608438
PMCPMC4066345
OpenAlexW2136164433

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.